Blockade of histamine receptor H1 augments immune checkpoint therapy by enhancing MHC-I expression in pancreatic cancer cells.

Autor: Zhong, PingShan1 (AUTHOR), Nakata, Kohei1,2,3 (AUTHOR) nakata.kohei.678@m.kyushu-u.ac.jp, Oyama, Koki1 (AUTHOR), Higashijima, Nobuhiro1 (AUTHOR), Sagara, Akiko1 (AUTHOR), Date, Satomi1 (AUTHOR), Luo, HaiZhen1 (AUTHOR), Hayashi, Masataka1 (AUTHOR), Kubo, Akihiro1 (AUTHOR), Wu, ChenYi1 (AUTHOR), He, Shan1 (AUTHOR), Yamamoto, Takeo4 (AUTHOR), Koikawa, Kazuhiro1 (AUTHOR), Iwamoto, Chika1 (AUTHOR), Abe, Toshiya1 (AUTHOR), Ikenaga, Naoki1 (AUTHOR), Ohuchida, Kenoki1 (AUTHOR), Morisaki, Takashi5 (AUTHOR), Oda, Yoshinao4 (AUTHOR), Kuba, Keiji6 (AUTHOR)
Zdroj: Journal of Experimental & Clinical Cancer Research (17569966). 5/8/2024, Vol. 43 Issue 1, p1-19. 19p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje